reference/19705349

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19705349

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study
endingPage	448
issn	1600-0609 0902-4441
issueIdentifier	4
pageRange	436-448
publicationName	European Journal of Haematology
startingPage	436
bibliographicCitation	Pungolino E, D'adda M, De Canal G, Trojani A, Perego A, Elena C, Lunghi F, Turrini M, Borin L, Iurlo A, Latargia ML, Carraro MC, Spina F, Artale S, Anghilieri M, Molteni A, Caramella M, Baruzzo G, Nichelatti M, Di Camillo B, Cairoli R. Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study. European J of Haematology. 2021 Jul 06;107(4):436–48. doi: 10.1111/ejh.13680.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d2231f2762c3daa258b135fe8cc3fe5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_685d37e44f019060cb8a5732a3a17e04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05b6d208616b0a6004e7517e8c32e04f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af2c79e41f52eb4224c604546988dff2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9950eef52f8c4f3fb68441e57254240b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_419ef13c1cc4b8e6ce62823486b9800d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d662751973d7487359c6fb9ed673b46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_490020773fd193e0e5c8aed51914ee93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3716af1db148ae2ff959858251d5f25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c179ac9a60da6e6d956796bb461b6c1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bab3b71cc50afb508964cf679ad5cee3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efae175f573991c8e34579043cd2a7cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0318-6616 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cb7535255cfed296c67da4dc8fee73f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ddfc347ca636eb01ba907f701720fed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae79bc0a7ea35f781c27a6e2c2c8858c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3871860ef676c375ad29849fcbca3fa3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6129-5007 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61f6f8d98ed960243955261e8e0ceb08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79bf3dff284ef00b78889275e01a6dab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3d33354c2cf21efdba191e7a9ac2217 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_617c4af0bc6e008e131dbb727e1918c4
date	2021-07-06^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9292618 https://doi.org/10.1111/ejh.13680 https://pubmed.ncbi.nlm.nih.gov/34139044
isPartOf	https://portal.issn.org/resource/ISSN/0902-4441 https://portal.issn.org/resource/ISSN/1600-0609 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3673
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0513854 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0028145 http://id.nlm.nih.gov/mesh/M0028143 http://id.nlm.nih.gov/mesh/M0503963 http://id.nlm.nih.gov/mesh/M0423646 http://id.nlm.nih.gov/mesh/M0203030 http://id.nlm.nih.gov/mesh/M0575206 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0024696 http://id.nlm.nih.gov/mesh/M0482811 http://id.nlm.nih.gov/mesh/M0027776 http://id.nlm.nih.gov/mesh/M0473784 http://id.nlm.nih.gov/mesh/M0190194
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D014411Q000187 http://id.nlm.nih.gov/mesh/D015973Q000187 http://id.nlm.nih.gov/mesh/D011743Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016179Q000378 http://id.nlm.nih.gov/mesh/D053614Q000378 http://id.nlm.nih.gov/mesh/D020869 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D053614Q000235 http://id.nlm.nih.gov/mesh/D000072000Q000378 http://id.nlm.nih.gov/mesh/D018799Q000235 http://id.nlm.nih.gov/mesh/D018799Q000378 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016022 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D015464Q000175 http://id.nlm.nih.gov/mesh/D001853Q000187 http://id.nlm.nih.gov/mesh/D015464Q000235 http://id.nlm.nih.gov/mesh/D010677 http://id.nlm.nih.gov/mesh/D015464Q000473 http://id.nlm.nih.gov/mesh/D001853Q000378 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016179Q000235 http://id.nlm.nih.gov/mesh/D001853Q000473 http://id.nlm.nih.gov/mesh/D014411Q000473 http://id.nlm.nih.gov/mesh/D018797Q000378 http://id.nlm.nih.gov/mesh/D018797Q000235 http://id.nlm.nih.gov/mesh/D014411Q000378 http://id.nlm.nih.gov/mesh/D000072000Q000235 http://id.nlm.nih.gov/mesh/D054316 http://id.nlm.nih.gov/mesh/D018528Q000378 http://id.nlm.nih.gov/mesh/D018528Q000235 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a24a0d100820c3a94d3a5def2bc5adc http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d2c6279569a5e5473d9efe0530fd802 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d95d62df86affba92c68aebdb789580 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c19b35feaf17e6688fd4993e5cead1c2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291

Showing number of triples: 1 to 106 of 106.